Drug factory · FDA FEI 3005804912

Eurofins CDMO Alphora Inc

2884 Portland Dr, Oakville, Canada

Canada: 1

Problems found, fixed voluntarily at FDA's last inspection, Jan 17, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2011: 1 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AvapritinibMakes the active ingredient and tests it Blueprint Medicines Corporation 72064-110, 72064-120, 72064-125 +2

FDA inspection history

EndedResultProgramProblems noted
Jan 17, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 11, 2019Problems found, fixed voluntarilyDrug Quality Assurance—
Apr 29, 2016No problems foundDrug Quality Assurance—
Feb 20, 2014Problems found, fixed voluntarilyDrug Quality Assurance—
Dec 2, 2011Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis; api manufacture.